Sign In
Sign Out
My Account
Subscribe
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
Special reports
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 3, 1997
View Archived Issues
New thrombin inhibitors from Novartis
Read More
Abbott reveals compounds for controlling synaptic transmission
Read More
Novartis prepares PKC inhibitors
Read More
NeoRx licenses Biostent to Schwarz
Read More
Menarini prepares thrombin inhibitors
Read More
IVAX submits NDA for Paxene
Read More
Uriach discloses new antifungal agents
Read More
More endothelin antagonists from SKB
Read More
Glaxo Wellcome discloses prodrugs of known 5-HT1-like agonist
Read More
SKKC and Chinese researchers develop new cancer vaccines
Read More
Pivotal trial of Therafectin enrolled
Read More
Cardioprotective and cerebroprotective agents from Pierre Fabre
Read More
Corvas begins phase Ia trial of rNAPc2
Read More
First test for HIV drug resistance introduced in the U.S.
Read More
Stromectol available in U.S. for parasitic infections
Read More
New experimental data on Asahi Chemical's ART-123
Read More
E-456, a minimum functional fragment of thrombomodulin from Asahi Chemical
Read More
Sheffield licenses Siemens multidose inhaler
Read More
Hematoprotective effects of PEG-rHuMGDF in mice
Read More
Electroporation shown to be effective for local delivery of agents for restenosis
Read More
Teva's Copaxone launched in U.S.
Read More
New experimental data for TPO reported by Kirin Brewery
Read More
IVAX's generic acyclovir tentatively approved
Read More
Antithrombotic effect of Yamanouchi's YM-337
Read More
NeoTherapeutics seeks FDA clearance for AIT-082 clinical trials
Read More
Inhibitors of IgE antibody production characterized by Teijin
Read More
MT-5, a novel neuritogenic agent from Riken and Taisho
Read More
Roberts licenses cardiovascular drug from Pfizer
Read More
Amplicor HIV-1 Monitor launched in Japan
Read More
Retinoids act as insulin sensitizers in mice
Read More
Atrix submits NDA for Atridox
Read More
Encouraging results for Targretin in CTCL
Read More
Sangstat and Gensia sign ciclosporin manufacturing agreement
Read More
Phase I/II results of MedImmune's MEDI-493 reported
Read More
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe